secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001493152-24-010901
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma regains NYSE American continued listing compliance
--------------------------------------------------------------------

- Received notification on March 21, 2024, resolving low selling price deficiency under Section 1003(f)(v).
- Common stock demonstrated sustained price improvement, curing the non-compliance.
- '.BC' indicator discontinued at market open on March 22, 2024; removed from noncompliant issuers list.
- NYSE American confirmed continued listing standard is now satisfied.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224010901/0001493152-24-010901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224010901/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-010901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer